Brian Millham - 22 Jan 2024 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and COO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Issuer symbol
CRM
Transactions as of
22 Jan 2024
Transactions value $
-$949,290
Form type
4
Filing time
23 Jan 2024, 20:51:55 UTC
Previous filing
22 Jan 2024
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $0 +655 $0 655 22 Jan 2024 Direct
transaction CRM Common Stock Options Exercise $268,974 +1,745 +2.66% $154.14 2,400 22 Jan 2024 Direct F1
transaction CRM Common Stock Options Exercise $434,213 +2,018 +84.08% $215.17 4,418 22 Jan 2024 Direct F1
transaction CRM Common Stock Options Exercise $459,550 +2,106 +47.67% $218.21 6,524 22 Jan 2024 Direct F1
transaction CRM Common Stock Options Exercise $2,083,253 +8,646 +1.33% $240.95 15,170 22 Jan 2024 Direct F1
transaction CRM Common Stock Sale -$4,122,260 -14,515 -95.68% $284 655 22 Jan 2024 Direct F1
transaction CRM Common Stock Sale -$73,021 -262 -40% $278.71 393 23 Jan 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Restricted Stock Units Options Exercise $0 -655 -50% $0 655 22 Jan 2024 Common Stock 655 $0 Direct F3, F4
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -1,745 -24.99% $0 5,237 22 Jan 2024 Common Stock 1,745 $154.14 Direct F5
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2,018 -6.67% $0 28,250 22 Jan 2024 Common Stock 2,018 $215.17 Direct F6
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2,106 -3.7% $0 54,774 22 Jan 2024 Common Stock 2,106 $218.21 Direct F7
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -8,646 -7.14% $0 112,398 22 Jan 2024 Common Stock 8,646 $240.95 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2023.
F2 Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through January 22, 2024.
F3 Restricted Stock Units convert to shares of common stock on a one-for-one basis.
F4 These restricted stock units vest as to 25% of the original grant on April 22, 2021, and vest as to 1/16 of the original grant quarterly thereafter.
F5 Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F6 Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F7 Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F8 Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.